ArticleInternational journal of oncology2019

RAC2 acts as a prognostic biomarker and promotes the progression of clear cell renal cell carcinoma.

Yuenan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.